Clinical Trials

ChemoID Randomized Clinical Trial – Glioblastoma (GBM) (NCT03632135)

The results of the trial “Standard chemotherapy versus chemotherapy chosen by cancer stem cell chemosensitivity testing in the management of patients with recurrent Glioblastoma Multiforme (GBM)” were published in Cell Reports Medicine (May 16, 2023).

ChemoID Randomized Clinical Trial – Platinum-Resistant Ovarian Cancer (NCT03949283)

The results of the trial “Standard Chemotherapy versus Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum -Resistant Ovarian Cancer” were published in Nature npj Precision Oncology (March 25, 2025)

ChemoID Randomized Clinical Trials Recently Concluded.

Pending Publication

Standard Chemotherapy versus Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer. NCT03949283

Concluded ChemoID Randomized Clinical Trials

The results of the trial “Standard chemotherapy versus chemotherapy chosen by cancer stem cell chemosensitivity testing in the management of patients with recurrent Glioblastoma Multiforme (GBM)” (NCT03632135) have been published in Cell Report Medicine (May 2, 2023).

Clinical Trials

ChemoID Randomized Clinical Trial – Glioblastoma (GBM) (NCT03632135)

ChemoID Randomized Clinical Trial – Platinum-Resistant Ovarian Cancer (NCT03949283)

ChemoID Randomized Clinical Trials Recently Concluded.

Concluded ChemoID Randomized Clinical Trials

Sample ChemoID® Patient's Test Report

Glioblastoma

Ovarian Adenocarcinoma

Registrati Ora su Hellspin Casino e Inizia a Vincere

Quick Links

Useful Links

Contact Info